Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR-12.4%
5Y CAGR-14.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-12.4%/yr
Quarterly compound
5Y CAGR
-14.3%/yr
Consistent
Percentile
P79
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202511.28%
Q3 2025-10.93%
Q2 20255.50%
Q1 2025-10.61%
Q4 202411.09%
Q3 2024-1.95%
Q2 2024-0.60%
Q1 2024-8.22%
Q4 20236.44%
Q3 20232.45%
Q2 2023-0.90%
Q1 2023-18.05%
Q4 202216.78%
Q3 20227.82%
Q2 2022-4.05%
Q1 2022-4.04%
Q4 202112.58%
Q3 2021-11.92%
Q2 202116.68%
Q1 2021-19.09%
Q4 202024.44%
Q3 2020-0.66%
Q2 2020-12.17%
Q1 2020-2.58%
Q4 201914.77%
Q3 2019-9.73%
Q2 201912.22%
Q1 2019-1.90%
Q4 2018-1.84%
Q3 20183.85%
Q2 20183.35%
Q1 2018-27.46%
Q4 201719.07%
Q3 2017-10.93%
Q2 2017-2.56%
Q2 201726.41%
Q4 20164.12%
Q3 20166.56%
Q2 2016-1.65%
Q1 2016-5.59%